Breast cancer cure rates almost doubled in combo therapy trial
newatlas.com
A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost doubled – the cure rate for patients with the most common kind of breast cancer. The findings suggest adopting a new treatment paradigm for the disease.
This is an automated archive made by the Lemmit Bot.

The original was posted on /r/tech by /u/chrisdh79 on 2025-01-28 11:14:36+00:00.

Original Title: Breast cancer cure rates almost doubled in combo therapy trial | A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved the cure rate for patients with the most common kind of breast cancer.